EUVIMEDEUVIMED entdecken
Crossref

Clinical application of O-RADS combined with CEUS and HE4 in the diagnosis of adnexal masses

Qian Fu, Ying Yuan, Zhaohui Zhou, Yi Huang, Yan Lin, Duanyuan Ouyang, Wenjuan Shi

Medical Ultrasonography · 2025

DOI: 10.11152/mu-4573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Ultrasonography, 2025. Verfasst von Qian Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shenzhen Maternity and Child Healthcare Hospital, Women and Children's Medical Center,Southern Medical University, Shenzhe…. Hauptthemen laut MEDLINE: Adnexal Diseases, Contrast Media, WAP Four-Disulfide Core Domain Protein 2.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to evaluate the diagnostic value of combining Ovarian-Adnexal Reporting and Data System (O-RADS), contrast-enhanced ultrasound (CEUS) scoring, and serum human epididymis protein 4 (HE4) in differentiating benign and malignant adnexal masses.Material and methods: A retrospective analysis was performed on 41 surgically resected adnexal masses confirmed by pathology between May 2022 and July 2025. All patients underwent routine ultrasound, CEUS, and preoperative serum HE4 testing. Adnexal masses were classified using O-RADS and assessed with three CEUS qualitative scores (initial enhancement time, enhancement intensity, and washout pattern) alongside HE4 levels.

Results

O-RADS alone showed a sensitivity of 69.2% for borderline and malignant adnexal masses (AUC 0.794). Adding CEUS increased sensitivity to 88.5% (AUC 0.906), and including HE4 further raised it to 96.2% (AUC 0.947). CEUS parameters differed significantly between benign and malignant adnexal masses (p < 0.001). The combined model markedly improved classification of intermediate-risk adnexal masses and reduced misclassification. Interobserver agreement was excellent (Kappa >0.85).

Conclusion

The integration of O-RADS with CEUS scoring and HE4 testing significantly improves the diagnostic accuracy for adnexal masses. This improvement is particularly notable in intermediate-risk adnexal masses. Our findings support the clinical utility of this integrated approach for risk stratification and decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adnexal DiseasesContrast MediaWAP Four-Disulfide Core Domain Protein 2HumansFemaleUltrasonographyRetrospective StudiesSensitivity and SpecificityDiagnosis, DifferentialAdultMiddle AgedImage EnhancementAgedReproducibility of Results

Substanzen

Contrast MediaWAP Four-Disulfide Core Domain Protein 2WFDC2 protein, human

Autor:innen und Institutionen

  • Department of Ultrasound, Shenzhen Maternity and Child Healthcare Hospital, Women and Children's Medical Center,Southern Medical University, Shenzhen, Guangdong Province.
  • Department of Ultrasound, Shenzhen Maternity and Child Healthcare Hospital, Women and Children's Medical Center,Southern Medical University, Shenzhen, Guangdong Province. yying0624@163.com.
  • Department of Gynecology Shenzhen Maternity and Child Healthcare Hospital, Women and Children's Medical Center, Southern Medical University, Shenzhen.

Zitieren

APA

Fu, Q., Yuan, Y., Zhou, Z., Huang, Y., Lin, Y., Ouyang, D., & Shi, W. (2025). Clinical application of O-RADS combined with CEUS and HE4 in the diagnosis of adnexal masses. Medical Ultrasonography. https://doi.org/10.11152/mu-4573

Vancouver

Fu Q, Yuan Y, Zhou Z, Huang Y, Lin Y, Ouyang D, et al. Clinical application of O-RADS combined with CEUS and HE4 in the diagnosis of adnexal masses. Medical Ultrasonography. 2025. doi:10.11152/mu-4573

BibTeX
@article{Fu2025,
  author = {Fu, Qian and Yuan, Ying and Zhou, Zhaohui and Huang, Yi and Lin, Yan and Ouyang, Duanyuan and Shi, Wenjuan},
  title = {Clinical application of O-RADS combined with CEUS and HE4 in the diagnosis of adnexal masses},
  journal = {Medical Ultrasonography},
  year = {2025},
  doi = {10.11152/mu-4573}
}
Kostenlos starten →